Astec Lifesciences informs about statement of investor complaints

18 Oct 2017 Evaluate

Astec Lifesciences has informed about Statement of Investor Complaints as per Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter ended 30th September, 2017.

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences Share Price

1060.65 8.50 (0.81%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
UPL 566.10
BASF India 5635.90
PI Industries 4115.15
Bayer CropScience 5726.95
Sumitomo Chemical India 513.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.